Identifying Another Piece in the Parkinson's Disease Pathology Puzzle
International Consortium Identifies and Validates Cellular Role of Priority Parkinson’s Disease Drug Target, LRRK2 Kinase
01-Feb-2016 -
An international public-private research consortium has identified and validated a cellular role of a primary Parkinson’s disease drug target, the LRRK2 kinase. This important finding illuminates a novel route for therapeutic development and intervention testing for Parkinson’s, the second most ...
GlaxoSmithKline
kinase inhibitors
mass spectrometry
+3